Evolus, Inc.
EOLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001570562
In the last 90 days, Evolus, Inc. insiders filed 0 open-market purchases and 1 sale; 158 institutions reported holding it in 13F filings for Q2 2026, worth $335.1M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Evolus, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 126 | 135 | +9 |
| Shares | 34.0M | 37.3M | +3.25M (+9.5%) |
| Value | $288.7M | $271.1M | −$17.6M (−6.1%) |
New holders (23)
Institutions that held Evolus, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (14)
Institutions that held Evolus, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 3,569,000 | $30.2M |
| Jefferies Financial Group Inc. | 500,000 | $4.23M |
| Monashee Investment Management LLC | 285,000 | $2.41M |
| Tri Locum Partners LP | 160,269 | $1.36M |
| Panagora Asset Management Inc | 29,661 | $250.9K |
| Jump Financial, LLC | 28,500 | $241.1K |
| SG Americas Securities, LLC | 17,214 | $146.0K |
| Dynamic Technology Lab Private Ltd | 11,062 | $94.0K |
| Point72 Asset Management, L.P. | 2,191 | $18.5K |
| CarsonAllaria Wealth Management, Ltd. | 1,253 | $10.6K |
| Advisory Services Network, LLC | 1,122 | $9.49K |
| Group One Trading, L.P. | 501 | $4.24K |
| GWM Advisors LLC | 234 | $1.98K |
| Point72 Middle East FZE | 197 | $1.67K |